Efficacy and Safety of Topical Essential Oil Extracted From Zingiber Cassumunar Rokb in Osteoarthritis

NCT ID: NCT01794260

Last Updated: 2013-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2/PHASE3

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-12-31

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this study are to assess short term efficacy and safety of of topical preparation of essential oil extracted from ZINGIBER CASSUMUNAR ROXB in patients suffering from osteoarthritic pain

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo cream

Placebo cream

Group Type PLACEBO_COMPARATOR

Placebo cream

Intervention Type DRUG

Plai cream

Cream from Zingiber cassumunar Roxb. extract

Group Type EXPERIMENTAL

Cream from Zingiber cassumunar Roxb. extract

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cream from Zingiber cassumunar Roxb. extract

Intervention Type DRUG

Placebo cream

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis: osteoarthritis of the knee at least on side with standard radiologic method within 6 weeks (Kellgren-Lawrence radiographic grading scale at least 1)
* Pain visual analog scale at rest at least 40 mm
* No previous analgesic treatment or receiving stable dose of analgesic drugs at least 2 weeks. If previously treated with antidepressants, glucosamine, chondroitin or diacerein, dosage should be stable for at least 3 months.
* Agree to attain non-pharmacologic treatment as prior to participate the study

Exclusion Criteria

* having an open wound or abnormal skin at site of application
* having diagnose with other chronic arthritis such as rheumatoid arthritis
* history of allergy to the extraction of Zingiber cassumunar Roxb
* pregnancy or breastfeeding
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mahidol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chuthamanee Suthisisang, Ph.D.

Role: STUDY_DIRECTOR

Department of Pharmacology, Faculty of Pharmacy, Mahidol University 447 Sri-Ayudhya Rd., Rajthevee, Bangkok 10400, Thailand

Suwimon Yeephu, M.Sc.

Role: PRINCIPAL_INVESTIGATOR

Faculty of Pharmacy, Srinakharinwirot University

Chuthamanee Suthisisant, Ph.D

Role: STUDY_CHAIR

Mahidol University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Medicine, Srinakharinwirot University

Ongkarak, Changwat Nakhon Nayok, Thailand

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chuthamanee Suthisisang, Ph.D.

Role: CONTACT

662-644-8700

Suwimon Yeephu, M.Sc.

Role: CONTACT

6686-9836644

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chuthamanee Suthisisang, Ph.D

Role: primary

662-644-8700

Suwimon Yeephu, M.Sc.

Role: backup

6686-9836644

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AFTA-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Osteoarthritis Topical Treatment
NCT01496326 COMPLETED PHASE2